Nyumbani › Limfadenopati ya Immunoblastic › Missouri › St. Louis
Majaribio ya kliniki ya Limfadenopati ya Immunoblastic katika St. Louis, MO
Masomo 3 ya Limfadenopati ya Immunoblastic yanatafuta washiriki katika vituo vya St. Louis na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
InaajiriHatua 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- na zaidi ya 2
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
InaajiriHatua 3
- Washington University in St. Louis, St Louis
A Registry for People With T-cell Lymphoma
InaajiriUtafiti wa uchunguzi
- Washington University (Data Collection Only), St Louis
Majaribio ya Limfadenopati ya Immunoblastic katika miji mingine
- New York City, NYUtafiti 5
- Chicago, ILUtafiti 4
- Houston, TXUtafiti 4
- Miami, FLUtafiti 4
- Durham, NCUtafiti 4
- Baldwin Park, CAUtafiti 3
- Ann Arbor, MIUtafiti 3
- Columbus, OHUtafiti 3
- Boston, MAUtafiti 3
- Atlanta, GAUtafiti 3
- New Haven, CTUtafiti 3
- Edison, NJUtafiti 3
Masomo mengine katika St. Louis
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 73
- Saratani ya MatitiUtafiti 64
- Saratani ya MetastasiUtafiti 54
- Kansari ya kolorektaliUtafiti 50
- Saratani ya ProstateUtafiti 46
- Saratani (aina zote)Utafiti 46
- Saratan ya MapafuUtafiti 39
- Kansari ya MayaiUtafiti 38
- Kansari ya PancreasUtafiti 33
- Saratani ya EndometrialUtafiti 29
- Kansari ya Seluli za Skwamu za Kichwa na ShingoUtafiti 28
- Kushindwa kwa MoyoUtafiti 26
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.